{"entity":{"type":"insider","cik":"0001620611","url":"/insider/0001620611","json_url":"/insider/0001620611.json","name":"Pellegrini Niamh Louise","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2020-08-10","last":"2021-03-12","span_basis":"filed_date"},"name_variants":[{"name":"Pellegrini Niamh Louise","source":"filing","n_filings":10,"first_seen":"2020-08-10","last_seen":"2021-03-12"}],"transactions":[{"id":4240663,"accession":"0001567619-21-006242","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-006242","line_url":"/filing/0001567619-21-006242#line-2","is_derivative":false,"issuer_cik":"0001444380","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001444380","owner_cik":"0001620611","owner_name":"Pellegrini Niamh Louise","owner_display_name":"Pellegrini Niamh Louise","owner_url":"/insider/0001620611","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":148.08,"price_display":"148.08","price_state":"stated","total_value":111060.0,"total_display":"111,060.00","total_whole":"111,060","shares_owned_after":39218.0,"shares_owned_after_display":"39,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-10","filed_date":"2021-03-12","scope":"insider"},{"id":4523431,"accession":"0001567619-21-003621","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-003621","line_url":"/filing/0001567619-21-003621#line-2","is_derivative":false,"issuer_cik":"0001444380","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001444380","owner_cik":"0001620611","owner_name":"Pellegrini Niamh Louise","owner_display_name":"Pellegrini Niamh Louise","owner_url":"/insider/0001620611","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":182.55,"price_display":"182.55","price_state":"stated","total_value":136912.5,"total_display":"136,912.50","total_whole":"136,913","shares_owned_after":30328.0,"shares_owned_after_display":"30,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-12","scope":"insider"},{"id":5074296,"accession":"0001567619-21-000977","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-000977","line_url":"/filing/0001567619-21-000977#line-2","is_derivative":false,"issuer_cik":"0001444380","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001444380","owner_cik":"0001620611","owner_name":"Pellegrini Niamh Louise","owner_display_name":"Pellegrini Niamh Louise","owner_url":"/insider/0001620611","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":169.8,"price_display":"169.80","price_state":"stated","total_value":127350.0,"total_display":"127,350.00","total_whole":"127,350","shares_owned_after":30328.0,"shares_owned_after_display":"30,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-13","scope":"insider"},{"id":2873003,"accession":"0001567619-20-021038","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-20-021038","line_url":"/filing/0001567619-20-021038","is_derivative":false,"issuer_cik":"0001444380","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001444380","owner_cik":"0001620611","owner_name":"Pellegrini Niamh Louise","owner_display_name":"Pellegrini Niamh Louise","owner_url":"/insider/0001620611","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":161.213,"price_display":"161.21","price_state":"stated","total_value":120909.75,"total_display":"120,909.75","total_whole":"120,910","shares_owned_after":30328.0,"shares_owned_after_display":"30,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-10","filed_date":"2020-12-14","scope":"insider","n_lines":2},{"id":2116118,"accession":"0001567619-20-019329","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-019329","line_url":"/filing/0001567619-20-019329#line-2","is_derivative":false,"issuer_cik":"0001444380","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001444380","owner_cik":"0001620611","owner_name":"Pellegrini Niamh Louise","owner_display_name":"Pellegrini Niamh Louise","owner_url":"/insider/0001620611","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":170.75,"price_display":"170.75","price_state":"stated","total_value":128062.5,"total_display":"128,062.50","total_whole":"128,063","shares_owned_after":30328.0,"shares_owned_after_display":"30,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-10","filed_date":"2020-11-12","scope":"insider"},{"id":2673265,"accession":"0001567619-20-018184","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-018184","line_url":"/filing/0001567619-20-018184#line-1","is_derivative":false,"issuer_cik":"0001444380","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001444380","owner_cik":"0001620611","owner_name":"Pellegrini Niamh Louise","owner_display_name":"Pellegrini Niamh Louise","owner_url":"/insider/0001620611","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1817.0,"shares_display":"1,817","price_per_share":165.0,"price_display":"165.00","price_state":"stated","total_value":299805.0,"total_display":"299,805.00","total_whole":"299,805","shares_owned_after":30328.0,"shares_owned_after_display":"30,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-22","filed_date":"2020-10-26","scope":"insider"},{"id":2673263,"accession":"0001567619-20-018057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-018057","line_url":"/filing/0001567619-20-018057#line-1","is_derivative":false,"issuer_cik":"0001444380","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001444380","owner_cik":"0001620611","owner_name":"Pellegrini Niamh Louise","owner_display_name":"Pellegrini Niamh Louise","owner_url":"/insider/0001620611","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":155.0,"price_display":"155.00","price_state":"stated","total_value":155000.0,"total_display":"155,000.00","total_whole":"155,000","shares_owned_after":32145.0,"shares_owned_after_display":"32,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-19","filed_date":"2020-10-21","scope":"insider"},{"id":2271604,"accession":"0001567619-20-017775","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-20-017775","line_url":"/filing/0001567619-20-017775#line-3","is_derivative":false,"issuer_cik":"0001444380","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001444380","owner_cik":"0001620611","owner_name":"Pellegrini Niamh Louise","owner_display_name":"Pellegrini Niamh Louise","owner_url":"/insider/0001620611","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":151.47,"price_display":"151.47","price_state":"stated","total_value":113602.5,"total_display":"113,602.50","total_whole":"113,603","shares_owned_after":33145.0,"shares_owned_after_display":"33,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-13","filed_date":"2020-10-13","scope":"insider"},{"id":2271595,"accession":"0001567619-20-017775","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-017775","line_url":"/filing/0001567619-20-017775#line-1","is_derivative":false,"issuer_cik":"0001444380","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001444380","owner_cik":"0001620611","owner_name":"Pellegrini Niamh Louise","owner_display_name":"Pellegrini Niamh Louise","owner_url":"/insider/0001620611","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":150.0,"price_display":"150.00","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","total_whole":"150,000","shares_owned_after":33145.0,"shares_owned_after_display":"33,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-09","filed_date":"2020-10-13","scope":"insider"},{"id":2129938,"accession":"0001567619-20-016681","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-016681","line_url":"/filing/0001567619-20-016681#line-2","is_derivative":false,"issuer_cik":"0001444380","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001444380","owner_cik":"0001620611","owner_name":"Pellegrini Niamh Louise","owner_display_name":"Pellegrini Niamh Louise","owner_url":"/insider/0001620611","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":139.14,"price_display":"139.14","price_state":"stated","total_value":104355.0,"total_display":"104,355.00","total_whole":"104,355","shares_owned_after":34145.0,"shares_owned_after_display":"34,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-10","filed_date":"2020-09-14","scope":"insider"},{"id":2501542,"accession":"0001567619-20-014651","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-20-014651","line_url":"/filing/0001567619-20-014651#line-3","is_derivative":false,"issuer_cik":"0001444380","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001444380","owner_cik":"0001620611","owner_name":"Pellegrini Niamh Louise","owner_display_name":"Pellegrini Niamh Louise","owner_url":"/insider/0001620611","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":140.11,"price_display":"140.11","price_state":"stated","total_value":105082.5,"total_display":"105,082.50","total_whole":"105,083","shares_owned_after":34145.0,"shares_owned_after_display":"34,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-10","filed_date":"2020-08-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001444380","name":"NEVRO CORP","url":"/issuer/0001444380","role":"Officer (Chief Commercial Officer)","n_filings":10,"first_seen":"2020-08-10","last_seen":"2021-03-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001620611","retrieved_at":"2026-08-27T13:18:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}